TRENBOPLEX 1 - Xt Labs

Among the most powerful anabolic agents ever studied, Methyltrienolone was introduced in 1965 as a potent oral form of trenbolone. Initially tested in cancer treatment, its use in humans was swiftly limited due to marked hepatotoxic effects. By the 1970s, it was adopted widely for laboratory research. Its structure resists metabolism and binds strongly to androgen receptors, making it a benchmark compound in steroidal assays, though unsuitable for therapeutic use due to its extreme liver strain.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about TRENBOPLEX 1 by Xt Labs, consult with your doctor or healthcare professional.